CPX-351 works synergistically in combination with FLT3 inhibitors against AML with FLT3-ITD

被引:3
|
作者
Edwards, David K.
Javidi-Sharifi, Nathalie
Rofelty, Angela
Gordon, Max
Roth-Carter, Riley
Tardi, Paul
Mayer, Lawrence
Tyner, Jeffrey W.
机构
关键词
D O I
10.1158/1538-7445.AM2017-1087
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1087
引用
收藏
页数:2
相关论文
共 50 条
  • [21] A novel combination regimen of BET and FLT3 inhibition for FLT3-ITD acute myeloid leukemia
    Lee, Lauren
    Hizukuri, Yoshiyuki
    Severson, Paul
    Powell, Benjamin
    Zhang, Chao
    Ma, Yan
    Narahara, Maiko
    Sumi, Hiroyuki
    Hernandez, Daniela
    Rajkhowa, Trivikram
    Bollag, Gideon
    Levis, Mark
    HAEMATOLOGICA, 2021, 106 (04) : 1022 - 1033
  • [22] FLT3 Inhibitors in AML
    Stone, R. M.
    ANNALS OF HEMATOLOGY, 2015, 94 (SUPPL 1) : 101 - 102
  • [23] FLT3 Inhibitors in AML
    Perl, Alexander
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S1 - S2
  • [24] FLT3 Inhibitors in AML
    Stone, R. M.
    ANNALS OF HEMATOLOGY, 2015, 94 : S101 - S102
  • [25] Molecular Analysis and In Vivo Efficacy Studies on a Novel Chemical-Series of FLT3 Inhibitors in Human FLT3-ITD AML
    Melgar, Katelyn
    Walker, MacKenzie
    Jiang, Jiang-kang
    Wison, Kelli
    Choi, Kwangmin
    Mulloy, James C.
    Thomas, Craig J.
    Starczynowski, Daniel T.
    BLOOD, 2016, 128 (22)
  • [26] Discovery of a highly selective FLT3 inhibitor with specific proliferation inhibition against AML cells harboring FLT3-ITD mutation
    Heng, Hao
    Zhi, Yanle
    Yuan, Haoliang
    Wang, Zhijie
    Li, Hongmei
    Wang, Shuxian
    Tian, Jieyi
    Liu, Haichun
    Chen, Yadong
    Lu, Tao
    Ran, Ting
    Lu, Shuai
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 163 : 195 - 206
  • [27] Erlotinib is effective against FLT3-ITD mutant AML and helps to overcome intratumoral heterogeneity via targeting FLT3 and Lyn
    Cao, Zhi-Xing
    Guo, Chuan-Jie
    Song, Xiaominting
    He, Jun-Lin
    Tan, Lu
    Yu, Si
    Zhang, Ruo-Qi
    Peng, Fu
    Peng, Cheng
    Li, Yu-Zhi
    FASEB JOURNAL, 2020, 34 (08): : 10182 - 10190
  • [28] CAR T-cells targeting FLT3 have potent activity against FLT3−ITD+ AML and act synergistically with the FLT3-inhibitor crenolanib
    Hardikkumar Jetani
    Irene Garcia-Cadenas
    Thomas Nerreter
    Simone Thomas
    Julian Rydzek
    Javier Briones Meijide
    Halvard Bonig
    Wolfgang Herr
    Jordi Sierra
    Hermann Einsele
    Michael Hudecek
    Leukemia, 2018, 32 : 1168 - 1179
  • [29] The combination of FLT3 and DNA methyltransferase inhibition is synergistically cytotoxic to FLT3/ITD acute myeloid leukemia cells
    E Chang
    S Ganguly
    T Rajkhowa
    C D Gocke
    M Levis
    H Konig
    Leukemia, 2016, 30 : 1025 - 1032
  • [30] The combination of FLT3 and DNA methyltransferase inhibition is synergistically cytotoxic to FLT3/ITD acute myeloid leukemia cells
    Chang, E.
    Ganguly, S.
    Rajkhowa, T.
    Gocke, C. D.
    Levis, M.
    Konig, H.
    LEUKEMIA, 2016, 30 (05) : 1025 - 1032